What Do FTC’s Aggressive Moves Against Biopharma Portend For 2024?

 
• By Brenda Sandburg

The Federal Trade Commission blocked or restricted several deals last year, broadening what it considers to be anticompetitive transactions. Stakeholders are looking to see if the agency will bring similar cases this year and what remedies it will seek to allow deals to go forward.

FTC statue - pink perspectives
US Federal Trade Commission derailed or restricted several transactions last year. • Source: Shutterstock

More from Compliance

More from Pink Sheet